Bioline Launches New JetSeq(TM) DNA Library Preparation Kits
(Thomson Reuters ONE) -
CINCINNATI, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, a
wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today
announced the expansion of the JetSeq(TM) DNA Library Preparation portfolio for
Next Generation Sequencing (NGS) sample preparation.
Developed in collaboration with Oxford Gene Technology (OGT), the new JetSeq(TM)
DNA Library Preparation Kits use pre-optimized buffers to provide maximum
reaction efficiency and highest conversion rates, enabling the preparation of
the highest quality NGS sequencing-ready, adapter-ligated DNA for Illumina's
Next Generation Sequencers. A combination of end repair and A-tailing followed
by direct ligation of customer supplied adapters, reduces clean-up steps and
hands-on time; significantly improving the yield and quality of sequence-ready
libraries, reducing the amount of DNA required. The new kits are supplied either
with polymerase, for PCR amplification with lower starting material, or PCR-free
kit where starting material is not limited.
Marco Calzavara, President of Bioline commented, "The release of the new
JetSeq(TM) DNA Library Preparation Kits compliments the JetSeq(TM) kit that we
launched just over a year ago, moving Bioline further into the NGS space. The
kits build on our extensive knowledge in the creation of highly efficient
enzymes and buffer formulation and give our customers even more choice in
library preparation, allowing them to tackle even the most challenging samples
with confidence, in this very fast moving field."
Richard L. Eberly, President, Chief Commercial Officer, stated, "We are excited
about the release of the new JetSeq(TM) DNA Library Preparation Kits. This
enhances our portfolio and gives a greater choice to our life science customers;
allowing faster preparation, reducing time to results, and increases throughput.
The development of the JetSeq(TM) family shows our commitment, not just to the
continued development and expansion of products from Bioline, but also to our
customers, giving them a greater choice of these high quality reagents."
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures,
markets and distributes a broad range of innovative diagnostic test kits, rare
reagents, specialty biologicals and components. Utilizing a variety of methods,
our diagnostic tests provide accuracy, simplicity and speed in the early
diagnosis and treatment of common medical conditions, such as infections and
lead poisoning. Meridian's diagnostic products are used outside of the human
body and require little or no special equipment. The Company's diagnostic
products are designed to enhance patient well-being while reducing the total
outcome costs of health care. Meridian has strong market positions in the areas
of gastrointestinal and upper respiratory infections and blood lead level
testing. In addition, Meridian is a supplier of rare reagents, specialty
biologicals and components used by organizations in the life science and agribio
industries engaged in research and by companies as components in the manufacture
of diagnostics. The Company markets its products and technologies to hospitals,
reference laboratories, research centers, diagnostics manufacturers and agribio
companies in more than 70 countries around the world. The Company's shares are
traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's website
address is www.meridianbioscience.com.
For Additional information:
For more information about Bioline, please visit http://www.bioline.com.
CONTACT:
Richard L. Eberly
President, Chief Commercial Officer
Meridian Bioscience, Inc.
Phone: 513.271.3700
Rick.eberly(at)meridianbioscience.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Meridian Bioscience, Inc. via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 08.02.2017 - 18:00 Uhr
Sprache: Deutsch
News-ID 522919
Anzahl Zeichen: 4664
contact information:
Town:
Cincinnati
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 132 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bioline Launches New JetSeq(TM) DNA Library Preparation Kits"
steht unter der journalistisch-redaktionellen Verantwortung von
Meridian Bioscience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
